NHS SY ICB -Community Pharmacy COVID-19 Triage, Assessment & Prescribing Service

Description

Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19. Lot 1: Since 2023, NHS England has instructed ICBs that covid antivirals should be available in a community setting, shifting the service from secondary care to a private provider. The current NICE recommended treatments were reviewed by SY Integrated Medicines Optimisation Committee (IMOC) and retained a RED traffic light status, meaning prescribing is recommended by services with specialist knowledge and experience.<br/>The ICB is committed to establishing prescribing services through community pharmacies and procurement of this service is an opportunity for contractors interested in delivering prescribing services to develop their workforce to gain specialist knowledge for the assessment and prescribing of COVID-19.<br/><br/>This notice is an intention to award a contract under the most suitable provider process.<br/><br/>The approximate lifetime value of the service is £40,000.<br/><br/>This is a new service.<br/><br/>The service will run from 01/06/2026 to 31/05/2028